1. Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis
- Author
-
Federica Chiappa, Giulia Perego, Anna Odone, Federica Balzarini, Vincenza Gianfredi, Carlo Signorelli, Giacomo Pietro Vigezzi, Giulia Cocciolo, S Salvati, Perego, G., Vigezzi, G. P., Cocciolo, G., Chiappa, F., Salvati, S., Balzarini, F., Odone, A., Signorelli, C., and Gianfredi, V.
- Subjects
safety ,medicine.medical_specialty ,Immunology ,CHILDREN ,Review ,immunogenicity ,immune response ,DOUBLE-BLIND ,Internal medicine ,Drug Discovery ,medicine ,Sore throat ,Live attenuated influenza vaccine ,Pharmacology (medical) ,Seroconversion ,Adverse effect ,VIRUS VACCINE ,Pharmacology ,intranasal live attenuated influenza vaccine ,business.industry ,MORTALITY ,adult ,H1N1 ,antibody response ,ADULTS ,TRIVALENT ,infant ,Vaccination ,Critical appraisal ,Infectious Diseases ,Systematic review ,Meta-analysis ,Medicine ,medicine.symptom ,CANDIDATE VACCINE ,business ,RESPONSES ,inactivated influenza vaccine - Abstract
Although influenza is a major public health concern, little is known about the use of spray live attenuated influenza vaccine (LAIV) among adults. For this reason, we conducted a systematic review and meta-analysis to investigate the efficacy and safety of LAIV, especially in adults with/without clinical conditions and children
- Published
- 2021